Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

40.17

+0.54 (1.36%)

At close: May 19, 2026, 4:00 PM EDT

39.00

-1.17 (-2.91%)

After-hours: May 19, 2026, 7:06 PM EDT

Enliven Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,447	915	1,101	571	430	237
Market Cap Growth	143.11%	-16.86%	92.67%	32.88%	81.78%	-84.71%
Enterprise Value	1,999	452.76	787.63	318.33	504.27	146.71
Last Close Price	40.17	15.40	22.50	13.84	16.36	9.00
PB Ratio	5.32	1.99	3.55	2.32	-5.60	2.75
P/TBV Ratio	5.30	1.90	3.42	2.00	-0.66	0.36
Debt / Equity Ratio	-	0	0	0	0	0.00
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.03	0.98	-1.04
Net Debt / EBITDA Ratio	3.92	3.87	3.02	2.88	1.96	1.75
Net Debt / FCF Ratio	6.90	6.57	4.28	4.12	2.31	1.92
Quick Ratio	39.38	27.92	19.69	9.78	7.78	12.52
Current Ratio	40.32	28.66	19.99	10.28	8.00	12.86
Return on Equity (ROE)	-21.64%	-26.95%	-32.04%	-44.90%	-47.39%	-60.29%
Return on Assets (ROA)	-24.60%	-29.84%	-35.08%	-47.04%	-43.85%	-55.77%
Return on Invested Capital (ROIC)	11252.40%	3617.23%	27227.70%	-19158.00%	1398.13%	1424.39%
Return on Capital Employed (ROCE)	-25.37%	-31.10%	-37.62%	-52.28%	-48.48%	-60.16%
Buyback Yield / Dilution	-21.96%	-20.38%	-32.43%	-1037.74%	10.25%	0.00%
Total Shareholder Return	-21.96%	-20.38%	-32.43%	-1037.74%	10.25%	0.00%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q